INSM vs REGN: Which Stock is Better?
Side-by-side comparison of Insmed Inc and Regeneron Pharmaceuticals Inc in 2026
INSM
Insmed Inc
$146.74
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | INSM | REGN | Winner |
|---|---|---|---|
| Market Cap | $31.67B | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 1.5% | 0.0% | INSM |
| Gross Margin | 79.7% | 44.6% | INSM |
Analyze INSM
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INSM or REGN a better investment?
Comparing INSM and REGN: Insmed Inc has a market cap of $31.67B while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INSM and REGN?
INSM (Insmed Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INSM or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INSM or REGN?
INSM has higher revenue growth at 1.5% vs 0.0% for REGN.
Which company is more profitable: INSM or REGN?
Insmed Inc (INSM) has higher gross margins at 79.7% compared to 44.6% for REGN.
Which is the larger company: INSM or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $31.67B for INSM.
Should I buy INSM or REGN in 2026?
Both INSM and REGN have investment merit. INSM trades at $146.74 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INSM and REGN stock?
Key differences: Market Cap ($31.67B vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (1.5% vs 0.0%), Gross Margin (79.7% vs 44.6%).